Harvard Bioscience Inc logo

HBIO

Harvard Bioscience Inc

$4.24

Earnings Summary

Revenue
$28.15Mn
Net Profits
$-1.82Mn
Net Profit Margins
-6.46%

Highlights

Revenue:

Harvard Bioscience Inc’s revenue fell -0.96% since last year same period to $28.15Mn in the Q4 2023. On a quarterly growth basis, Harvard Bioscience Inc has generated 11% jump in its revenue since last 3-months.

Net Profits:

Harvard Bioscience Inc’s net profit fell -9.12% since last year same period to $-1.82Mn in the Q4 2023. On a quarterly growth basis, Harvard Bioscience Inc has generated -46.73% fall in its net profits since last 3-months.

Net Profit Margins:

Harvard Bioscience Inc’s net profit margin fell -10.19% since last year same period to -6.46% in the Q4 2023. On a quarterly growth basis, Harvard Bioscience Inc has generated -32.19% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Harvard Bioscience Inc post its latest quarter earnings

EPS Estimate Current Quarter
0.02
EPS Estimate Current Year
0.02

Highlights

EPS Estimate Current Quarter:

Harvard Bioscience Inc’s earning per share (EPS) estimates for the current quarter stand at 0.02 - a -60% fall from last quarter’s estimates.

EPS Estimate Current Year:

Harvard Bioscience Inc’s earning per share (EPS) estimates for the current year stand at 0.02.

Key Ratios

Key ratios of the Harvard Bioscience Inc post its Q4 2023 earnings

Earning Per Share (EPS)
0.04
Return on Assets (ROA)
0.01
Return on Equity (ROE)
-0.05

Highlights

Earning Per Share (EPS):

Harvard Bioscience Inc’s earning per share (EPS) jumped 0% since last year same period to 0.04 in the Q4 2023. This indicates that the Harvard Bioscience Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Harvard Bioscience Inc’s return on assets (ROA) stands at 0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Harvard Bioscience Inc’s return on equity (ROE) stands at -0.05.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-03-07
0.05
0.04
-20%
2023-08-08
0.06
0.04
-33.33%
2023-04-26
0.05
0.06
20%
2023-11-07
0.04
0.01
-75%